tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Niagen Bioscience price target raised to $12 from $11 at H.C. Wainwright
PremiumThe FlyNiagen Bioscience price target raised to $12 from $11 at H.C. Wainwright
2M ago
Niagen Bioscience’s Robust Growth and Strategic Initiatives Drive Buy Rating
Premium
Ratings
Niagen Bioscience’s Robust Growth and Strategic Initiatives Drive Buy Rating
2M ago
Niagen Bioscience Reports Strong Q2 Growth and Outlook
Premium
Company Announcements
Niagen Bioscience Reports Strong Q2 Growth and Outlook
2M ago
Niagen Bioscience licenses potential Parkinson’s therapy
PremiumThe FlyNiagen Bioscience licenses potential Parkinson’s therapy
3M ago
Niagen Bioscience Approves Equity Plan Amendment
Premium
Company Announcements
Niagen Bioscience Approves Equity Plan Amendment
4M ago
Niagen Bioscience price target raised to $16 from $13 at Canaccord
Premium
The Fly
Niagen Bioscience price target raised to $16 from $13 at Canaccord
4M ago
Niagen Biosciences Reports Strong Q1 2025 Growth
PremiumCompany AnnouncementsNiagen Biosciences Reports Strong Q1 2025 Growth
5M ago
Niagen Bioscience’s Clinical Expansion and Strong Financial Performance Drive Buy Rating
Premium
Ratings
Niagen Bioscience’s Clinical Expansion and Strong Financial Performance Drive Buy Rating
5M ago
Niagen Bioscience Reports Strong Q1 2025 Growth
Premium
Company Announcements
Niagen Bioscience Reports Strong Q1 2025 Growth
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100